The Magazine for Sleep Professionals
Monday, April 6, 2026
Eurosets has announced the full commercial release of its novel ECMOlife system for Extracorporeal Life Support (ECLS). This release comes after a successful pre-market clinical evaluation in which critically ill patients were supported by the device for a cumulative period of over 400 days with the longest individual treatment lasting […]
The FDA has granted Abiomed 510(k) clearance for an all-in-one, compact cardiopulmonary bypass system called the Abiomed Breethe OXY-1 System™. The ECMO system provides cardiopulmonary bypass support for patients whose lungs can no longer provide sufficient end-organ oxygenation. The 510(k) clearance is to pump, oxygenate, and remove carbon dioxide from […]
A new study published online in the Annals of the American Thoracic Society examines whether the amount of RNA, or genomic load, of SARS-CoV-2 detected in swab tests of patients being admitted to the hospital with viral pneumonia is associated with more severe COVID-19. SARS-CoV-2 is the virus that causes COVID-19. Previous studies on […]
A new study published online in the Annals of the American Thoracic Society examines ways to increase the use of prone positioning for patients with severe acute respiratory distress syndrome (ARDS) and develops specific implementation strategies that can assist in clinicians’ response to the COVID-19 pandemic. Prone positioning has been shown to reduce mortality […]
ALung Technologies, Inc. announced the recent initiation of commercial development of its next-generation artificial lung, which expands the Company’s focus on highly efficient gas exchange devices and also broadens its applicable market. The Company’s current product, the Hemolung® Respiratory Assist System (RAS), is the only fully comprehensive extracorporeal carbon dioxide removal […]
Abiomed, maker of the Impella heart pump, has acquired Breethe, developer of a novel extracorporeal membrane oxygenation (ECMO) system that will complement and expand Abiomed’s product portfolio to more comprehensively serve the needs of patients whose lungs can no longer provide sufficient oxygenation, including patients suffering from cardiogenic shock or respiratory […]
Fresenius Medical Care North America Announces First Extracorporeal Membrane Oxygenation (ECMO) System Cleared for Long-Term Use Fresenius Medical Care North America (FMCNA) announced that the FDA has cleared Novalung®, a heart and lung support system for the treatment of acute respiratory or cardiopulmonary failure. Novalung is the first extracorporeal membrane oxygenation (ECMO) […]
